Page 1 of Clinical Trials for Drug Erlotinib hydrochloride, 620 Total Matches
- 1Not yet recruitingLast Updated: May 4, 2012Condition(s): Malignant Peritoneal Mesothelioma
- 2RecruitingLast Updated: May 9, 2012Condition(s): Advanced Cancer
- 3RecruitingLast Updated: May 22, 2012Condition(s): Solid Tumors
- 4Not yet recruitingLast Updated: March 15, 2012Condition(s): Lung Cancer
- 5CompletedLast Updated: August 6, 2009Condition(s): Malignant Brain Tumor; Brain Stem Glioma,
- 6CompletedLast Updated: September 20, 2011Condition(s): Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
- 7CompletedLast Updated: August 5, 2010Condition(s): Drug/Agent Toxicity by Tissue/Organ; Head and Neck Cancer; Lung Cancer; Ovarian Cancer
- 8RecruitingLast Updated: January 17, 2012Condition(s): Metastatic Non-Small Cell Lung Cancer
- 9CompletedLast Updated: May 9, 2012Condition(s): Lung Cancer
- 10TerminatedLast Updated: January 20, 2010Condition(s): Cervical Cancer
- 11RecruitingLast Updated: February 23, 2012Condition(s): Ovarian Cancer
- 12Enrolling by invitationLast Updated: February 29, 2012Condition(s): Ependymoma
- 13RecruitingLast Updated: September 20, 2011Condition(s): Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Verrucous Carcinoma of the Larynx; Stage IV Verrucous Carcinoma of the Oral Cavity; Tongue Cancer; Untreated Metastatic Squamous Neck Cancer With Occult Primary
- 14RecruitingLast Updated: July 19, 2011Condition(s): Colorectal Cancer
- 15RecruitingLast Updated: March 19, 2012Condition(s): Solid Tumors; Advanced Cancer
- 16CompletedLast Updated: June 30, 2011Condition(s): Carcinoma, Non-Small-Cell Lung
- 17CompletedLast Updated: April 12, 2012Condition(s): Non Small Cell Lung Cancer
- 18RecruitingLast Updated: January 17, 2012Condition(s): Precancerous Conditions
- 19Active, not recruitingLast Updated: April 10, 2009Condition(s): Lung Cancer
- 20RecruitingLast Updated: October 20, 2011Condition(s): Brain Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Erlotinib+hydrochloride
